An update from Compass ( ($COMP) ) is now available. On September 22, 2025, Compass, Inc. entered into a merger agreement under which its wholly ...

We came across a bullish thesis on Compass, Inc. on Valueinvestorsclub.com by TooCheapToIgnore. In this article, we will ...

Revenue Grew 23.6% YoY; At High-end of Revenue Guide 851 Gross Principal Agents Joined; An All-time High Operating Cash Flow Grew 102% YoY to $75.5 million Scott Wahlers, Chief Financial Officer of ...

Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.

Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the 12 best multibagger stocks to buy heading into 2026. On December 3, ...

We recently compiled a list of the 10 Best Low Priced Stocks to Invest in Now. In this article, we are going to take a look at where Compass, Inc. (NYSE:COMP) stands against the other low priced ...

Here is how Compass Therapeutics, Inc. (CMPX) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

NOLA Home Realty Group, a real estate team previously operating independently, has joined Compass Inc., the largest residential real estate brokerage in the U.S. by sales volume. Led by broker-owners ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/compass-inc-reports-record-second-quarter-2025-results-302517839.html ...

Revenue in Q1 Grew 28.7% YoY and Organic Revenue Grew 14.6% YoY Quarterly Market Share Grew 125bps YoY to a Record 6.0%; Organic Share Was Up 82bps Reffkin continued, "Looking ahead, while recent ...